Literature DB >> 17403314

[The cellular location and significance of p38alpha/beta isoforms in the lumbar spinal cord of the bone cancer pain rats].

Hang Dong1, Yu-Ke Tian, Hong-Bing Xiang, Xue-Bi Tian, Xiao-Gao Jin.   

Abstract

OBJECTIVE: To examine the cellular distribution and location of p38alpha/beta isoforms in the lumbar spinal cord of the bone cancer pain rats.
METHODS: Twenty SD female rats weighing 180 - 220 g were randomly divided into 2 groups (n = 10 each): group A (control group): intra-tibial injection of 3 microl Hank's solution; group B (model group): intra-tibial injection of 3 microl MADB-106 mammary gland carcinoma cells of rats (4.8 x 10(3)/microl). Mechanical withdrawal threshold and radiant heat threshold of rats' hind paws were measured every other day from one day before operation until 14 days later. The lumbar 4 ~ 5 spinal cord was removed on the 14th day. The cellular distribution and location of the spinal p38alpha/beta immunoreactivity were detected by immunohistochemistry SABC and double immunofluorescence methods.
RESULTS: No significant differences in mechanical withdrawal threshold and radiant heat threshold were found at all time points in group A. During the first 6 days of post-operation there was obvious difference in radiant heat stimulus between group A and B (P < 0.05); on the 14th day after operation, mechanical pain threshold and radiant heat threshold in group B were significantly different from that of group A (P < 0.05). The p38alpha/beta immunoreactivity of group B in laminae I approximately IV of dorsal horn showed stronger staining than group A (P < 0.05). Double immunofluorescence confocal micrographs showed that spinal p38alpha and the neuronal marker neuronal N (NeuN) were colocalized in the dorsal horn, indicating that p38alpha was expressed in neurons. Double immunofluorescence micrographs demonstrated that antibodies against p38beta and the microglia marker OX42 labeled the same cell, indicating that p38beta was expressed in microglia.
CONCLUSION: Our studies indicate that p38alpha and p38beta are involved in the generation and maintenance of bone cancer pain states. p38alpha is predominantly expressed in neurons, while p38beta is expressed in microglia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403314

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  6 in total

1.  Inhibitory effects of intrathecal p38β antisense oligonucleotide on bone cancer pain in rats.

Authors:  Hang Dong; Hong-Bing Xiang; Da-Wei Ye; Xue-Bi Tian
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Downregulation of PI3Kcb utilizing adenovirus-mediated transfer of siRNA attenuates bone cancer pain.

Authors:  Huan-Jun Huang; Mei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation.

Authors:  Shanshan Zhu; Chenchen Wang; Yuan Han; Chao Song; Xueming Hu; Yannan Liu
Journal:  Mediators Inflamm       Date:  2015-11-30       Impact factor: 4.711

4.  P2Y12 receptor-mediated activation of spinal microglia and p38MAPK pathway contribute to cancer-induced bone pain.

Authors:  Mingjuan Liu; Ming Yao; Hanqi Wang; Longsheng Xu; Ying Zheng; Bing Huang; Huadong Ni; Shijie Xu; Xuyan Zhou; Qingquan Lian
Journal:  J Pain Res       Date:  2017-02-16       Impact factor: 3.133

5.  Interleukin 33-mediated inhibition of A-type K+ channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice.

Authors:  Yiru Wang; Xinyi Wang; Renfei Qi; Ying Lu; Yu Tao; Dongsheng Jiang; Yufang Sun; Xinghong Jiang; Chunfeng Liu; Yuan Zhang; Jin Tao
Journal:  Theranostics       Date:  2022-02-14       Impact factor: 11.556

6.  Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.

Authors:  Gerardo A Morfini; Daryl A Bosco; Hannah Brown; Rodolfo Gatto; Agnieszka Kaminska; Yuyu Song; Linda Molla; Lisa Baker; M Natalia Marangoni; Sarah Berth; Ehsan Tavassoli; Carolina Bagnato; Ashutosh Tiwari; Lawrence J Hayward; Gustavo F Pigino; D Martin Watterson; Chun-Fang Huang; Gary Banker; Robert H Brown; Scott T Brady
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.